Here are the latest quarterly results of GLAND PHARMA. For more details, see the GLAND PHARMA financial fact sheet and GLAND PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
3
Mar-24* |
3
Jun-24* |
3
Sep-24* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 9,383 | 7,850 | 12,087 | 13,734 | 15,452 | 15,375 | 14,017 | 14,058 | |
Other income | Rs m | 615 | 389 | 375 | 532 | 374 | 421 | 514 | 597 | |
Turnover | Rs m | 9,998 | 8,240 | 12,462 | 14,266 | 15,825 | 15,796 | 14,531 | 14,655 | |
Expenses | Rs m | 6,487 | 6,166 | 9,147 | 10,493 | 11,888 | 11,788 | 11,373 | 11,088 | |
Gross profit | Rs m | 2,896 | 1,120 | 2,940 | 3,241 | 3,564 | 3,587 | 2,644 | 2,971 | |
Depreciation | Rs m | 376 | 375 | 653 | 813 | 1,053 | 926 | 920 | 938 | |
Interest | Rs m | 26 | 22 | 49 | 60 | 53 | 100 | 56 | 61 | |
Profit before tax | Rs m | 3,109 | 1,112 | 2,613 | 2,899 | 2,832 | 2,982 | 2,182 | 2,568 | |
Tax | Rs m | 789 | 325 | 672 | 958 | 913 | 1,058 | 745 | 932 | |
Profit after tax | Rs m | 2,319 | 787 | 1,941 | 1,941 | 1,919 | 1,924 | 1,438 | 1,635 | |
Gross profit margin | % | 30.9 | 14.3 | 24.3 | 23.6 | 23.1 | 23.3 | 18.9 | 21.1 | |
Effective tax rate | % | 25.4 | 29.2 | 25.7 | 33.0 | 32.2 | 35.5 | 34.1 | 36.3 | |
Net profit margin | % | 24.7 | 10.0 | 16.1 | 14.1 | 12.4 | 12.5 | 10.3 | 11.6 | |
Diluted EPS | Rs | 14.1 | 4.8 | 11.8 | 11.8 | 11.6 | 11.7 | 8.7 | 9.9 | |
Diluted EPS (TTM) | Rs | 60.0 | 47.4 | 45.3 | 42.4 | 40.0 | 46.9 | 43.8 | 42.0 | |
Subscriber Feature |
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.